Innovation at Scale-Healthy Returns

Since stepping in as CEO just over a year ago, Albert Bourla has already been named America's top pharmaceutical CEO by Institutional Investor. In a rare interview, CNBC's Meg Tirrell spoke with him about his company's multipronged fight against Covid-19 and Pfizer's future at CNBC's Healthy Returns Virtual Summit.